Myelodysplastic Syndromes (MDS): Classification, Prognosis, and Therapy
MDS are clonal hematopoietic stem cell disorders with dysplasia, cytopenias, and risk of AML transformation. Median age 70; incidence ~4/100,000.
WHO 2022 / ICC Classification Highlights
- Defined by cytopenias + dysplasia (≥10% in lineage) + cytogenetics/molecular.
- Key subtypes: MDS with low blasts (MDS-LB), MDS with increased blasts (MDS-IB1/2), MDS with SF3B1 mutation (ring sideroblasts), MDS with isolated del(5q), MDS/MPN overlap.
- TP53 mutation (multi-hit) = distinct aggressive entity.
Prognostic Scoring
- IPSS-R (Revised): Cytogenetics, blast %, cytopenias → 5 risk groups (Very Low → Very High). Median OS: 8.8 yr (VL) to 0.8 yr (VH).
- IPSS-M (Molecular): Adds mutations (TP53, FLT3, RAS, SF3B1, etc.) — more precise.
- Molecular IPSS (IPSS-M) now preferred for treatment decisions.
Treatment by Risk
| Risk | Approach |
|---|---|
| Lower (IPSS-R VL/Low; IPSS-M VL/Low) | Supportive: ESA (epoetin) for anemia; G-CSF for infections; transfusions (RBC/platelets); iron chelation if ferritin >1000. Luspatercept (erythroid maturation agent) for ring sideroblast+ MDS post-ESA. |
| Higher (Int/High/VH) | Hypomethylating agents (HMA): Azacitidine (SC/IV q28d) or Decitabine (IV q28d). Goal: delay AML, improve survival. Venetoclax + HMA (emerging). Allo-HSCT only curative — refer early (age/fitness permitting). |
| del(5q) isolated | Lenalidomide (transfusion independence ~67%). |
Supportive Care Essentials
- Transfusion thresholds individualized; pathogen-reduced/irradiated products.
- Infection prophylaxis (PJP if on HMA/immunosuppressed).
- Vaccinations (non-live); advance care planning.
Monitoring
CBC every 1–3 months; marrow every 6–12 months or at progression; molecular tracking (VAF trends).
Genetic Disorders - Related Articles
- Keratin Complex Treatments: Risks, Hazards, and Safety Precautions
- Thalassemia Inheritance: Alpha & Beta Trait Combinations Explained
- Cataplexy: Understanding Causes, Symptoms & Triggers
- Phenotype: How Genes Manifest
- Understanding Elevated ssDNA: Causes and Implications
- Parasite Infection Symptoms: What to Look For in Stool
- Transvestism and Mental Health: No Inherent Link to Personality Disorders
